B Cells Induce Tolerance by Presenting Endogenous Peptide-IgG on MHC Class II Molecules via an IFN-γ-Inducible Lysosomal Thiol Reductase-Dependent Pathway1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.181.2.1153PMID 18606668PMCID PMC2587118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

  2007cited by this paper
• Autophagy in MHC class II antigen processing.

  2007cited by this paper
• Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.

  2006cited by this paper
• Functional Requirements for the Lysosomal Thiol Reductase GILT in MHC Class II-Restricted Antigen Processing1

  2006cited by this paper
• B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis.

  2006cited by this paper
• Exposure of the Promonocytic Cell Line THP-1 to Escherichia coli Induces IFN-γ-Inducible Lysosomal Thiol Reductase Expression by Inflammatory Cytokines1

  2006cited by this paper
• Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells.

  2006cited by this paper
• Autophagy and Antigen Presentation

  2005cited by this paper
• Central tolerance: learning self-control in the thymus

  2005cited by this paper
• Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens.

  2005cited by this paper
• Mechanisms of Gene Therapy for Tolerance: B7 Signaling Is Required for Peptide-IgG Gene-Transferred Tolerance Induction1

  2005cited by this paper
• Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins.

  2005cited by this paper
• Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing

  2005cited by this paper
• Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

  2005cited by this paper
• Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy

  2005cited by this paper
• A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.

  2004cited by this paper
• Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-β?

  2004cited by this paper
• Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

  2003cited by this paper
• Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy

  2003cited by this paper
• Gene Transfer of Ig-Fusion Proteins Into B Cells Prevents and Treats Autoimmune Diseases1

  2002cited by this paper
• In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment.

  2002cited by this paper
• The enemy within: keeping self-reactive T cells at bay in the periphery

  2002cited by this paper
• Disulfide reduction in major histocompatibility complex class II-restricted antigen processing by interferon-gamma-inducible lysosomal thiol reductase.

  2002cited by this paper
• Absence of γ-Interferon–inducible Lysosomal Thiol Reductase in Melanomas Disrupts T Cell Recognition of Select Immunodominant Epitopes

  2002cited by this paper
• Protein translocation across membranes.

  2001cited by this paper
• Defective Antigen Processing in GILT-Free Mice

  2001influential reference
• In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses

  2001cited by this paper
• Gene Therapeutic Approaches to Induction and Maintenance of Tolerance

  2001cited by this paper
• Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis.

  2000cited by this paper
• Mechanisms of Tolerance Induction by a Gene-Transferred Peptide-IgG Fusion Protein Expressed in B Lineage Cells1 2

  2000cited by this paper
• Cytoplasmic Processing Is a Prerequisite for Presentation of an Endogenous Antigen by Major Histocompatibility Complex Class II Proteins

  2000cited by this paper
• Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT).

  2000cited by this paper
• Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo1

  2000cited by this paper
• The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.

  1999cited by this paper
• Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness.

  1999cited by this paper
• Mechanisms of MHC class I--restricted antigen processing.

  1998cited by this paper
• Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients.

  1997cited by this paper
• Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules

  1997cited by this paper
• Genetically Transferred Central and Peripheral Immune Tolerance via Retroviral-Mediated Expression of Immunogenic Epitopes in Hematopoietic Progenitors or Peripheral B Lymphocytes

  1997cited by this paper
• An Intralysosomal hsp70 Is Required for a Selective Pathway of Lysosomal Protein Degradation

  1997cited by this paper
• A Receptor for the Selective Uptake and Degradation of Proteins by Lysosomes

  1996influential reference
• Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.

  1996cited by this paper
• Epitope-specific tolerance induction with an engineered immunoglobulin.

  1996cited by this paper
• Tolerogenicity of resting and activated B cells

  1994cited by this paper
• MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.

  1994cited by this paper
• Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

  1993cited by this paper
• B cells turn off virgin but not memory T cells.

  1992cited by this paper
• Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens

  1992cited by this paper
• [Protein translocation across membranes].

  1991cited by this paper
• Sequence analysis of peptides bound to MHC class II molecules

  1991cited by this paper
• Small B Cells as Antigen Presenting Cells in the Induction of Tolerance to Soluble Protein Antigens: A Dissertation

  1991cited by this paper
• On the complexity of self

  1991cited by this paper
• An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

  1990cited by this paper
• HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells

  1989cited by this paper
• Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers.

  1977cited by this paper
• Loss of carrier-determined tolerance in vitro with loss of receptor blockade.

  1976cited by this paper
• Isologous IgG-induced tolerance to benzyl penicilloyl

  1976cited by this paper
• Effect on tolerance induction of the mode of attachment of the hapten the carrier.

  1975cited by this paper

• Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner

  2019cites this paper
• The regulatory roles of B cell subsets in transplantation

  2018cites this paper
• Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells

  2017cites this paper
• Cell Therapy to Induce Allograft Tolerance: Time to Switch to Plan B?

  2015cites this paper
• Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cells.

  2014cites this paper
• Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?

  2013cites this paper
• Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapies.

  2013cites this paper
• Expanding roles for GILT in immunity.

  2013cites this paper
• Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se

  2013cites this paper
• Tregitope update: mechanism of action parallels IVIg.

  2013cites this paper
• Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance

  2012cites this paper
• Mice deficient in MIM expression are predisposed to lymphomagenesis

  2012cites this paper
• Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.

  2012cites this paper
• Immunobiology of B Cells in Inflammatory Bowel Disease

  2012cites this paper
• Gene therapy for immunologic tolerance: using bone marrow-derived cells to treat autoimmunity and hemophilia.

  2011cites this paper
• Protein transduction for tolerance induction.

  2011cites this paper
• B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance

  2011cites this paper
• B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE.

  2011cites this paper
• Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.

  2011cites this paper
• B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.

  2010cites this paper
• Gene therapy for immunological tolerance: using ‘transgenic’ B cells to treat inhibitor formation

  2010cites this paper
• Gene therapy for tolerance and vice versa: a case for hemophilia.

  2010cites this paper
• Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells

  2010cites this paper
• Tolerance Induction and The Immunobiology of Factor VIII in Hemophilia A

  2010cites this paper
• Gene expression profiles of two B-complex disparate, genetically inbred Fayoumi chicken lines that differ in susceptibility to Eimeria maxima.

  2009cites this paper
• The molecular mechanisms of immunomodulation and tolerance induction to factor VIII

  2009cites this paper
• Factor VIII Inhibitors: Risk Factors and Methods for Prevention and Immune Modulation

  2009cites this paper
• Strategies to modulate immune responses: a new frontier for gene therapy.

  2009cites this paper
• Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.

  2009cites this paper